Xu J, Liu Z, Bai H, Dong G, et al. Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial. JAMA Oncol 2022 Jul 21. pii: 2794634. doi: 10.1001/jamaoncol.2022.2719.
PMID: 35862035